Preoperative evaluation of the curability of gastric and cardia cancer is important to avoid risks of unnecessary surgery. Our previous study has reported several clinical parameters associated with incurable gastric surgery. In this study, we aimed to evaluate the correlation between CA125 and the curability of gastric and cardia cancer.
Introduction
Gastric and cardia cancer are one of the most commonly diagnosed malignancies in the world. Gastric cancer is the fifth most common cancer, [1] and the third leading cause of cancer death. [2] The number of gastric cancer patients in China is the largest worldwide, which accounts for >40% of new gastric cancer cases and deaths worldwide in 2012. [2] Most of gastric cancer cases are found in developing countries, and East Asia is with a high fatality rate as well.
In China, the 5-year survival of gastric cancer has improved from 15.3% for patients diagnosed during 1995-1999 to 29.0% during 2000-2004 and 31.3% during [2005] [2006] [2007] [2008] [2009] . [3] The improvement of prognosis is the consequence of advanced surgical techniques and adjuvant treatments. Radical surgery with adequate surgical resection and lymphadenectomy is regarded as the only curative way either for early gastric cancer or nonmetastatic advanced gastric cancer. [4] However, owing to its nonspecific symptoms and highly invasive characteristics, most cases are diagnosed at the advanced stage of disease. [5] It is reported that only 20% to 50% of patients who underwent surgical exploration can be operated with curative intent surgery. [6, 7] Taken the risk of operation into consideration, it is not suggested for patients with incurable disease. Therefore, it will be of importance to confirm whether one patient is appropriate to receive operation preoperatively.
In our previous study, [8] we reported the association between clinical parameters and the curability of gastric cancer, in which the curability was defined as the possibility to undergo radical surgery, instead of palliative resection, exploratory surgery, and bypass surgery. Some commonly used serum tumor markers were not studied, however. Serum tumor markers, such as Cancer antigen 125 (CA125), play important roles in the diagnosis, management, and evaluation of prognosis, recurrence, and metastasis.
CA125 is a widely used tumor marker, which is a glycoprotein expressed in epithelium lining body cavities, and regarded as the most reliable serum marker for ovarian carcinoma. [9] It has been found to show high sensitivity and specificity in the diagnosis of several digestive tract cancers. [10] Nevertheless, the correlation between CA125 and the curability of gastric or cardia cancer has not been reported before. On the basis of our previous results, we will study the association of CA125 and the curability of gastric and cardia cancer, and try to provide some evidence for clinical management of gastric and cardia cancer patients.
Method

Patients
We collected cases of primary gastric and cardia cancer surgically treated in Zhejiang Cancer Hospital (Hangzhou, China) from January 2007 to January 2011 retrospectively. Patients of T3/T4 gastric or cardia cancer with the data of preoperative CA125 were included. Those who did not receive operation, had other cancers simultaneously, or received preoperative chemotherapy or radiotherapy were excluded. This research was approved by Medical Ethics Committee, Zhejiang Medical College. Written informed consent was obtained from each patient before study enrolment.
One hundred forty-four cases of incurable gastric and cardia cancer were selected, 36 of them underwent palliative resection, and the other 108 underwent exploratory surgery or bypass surgery. Meanwhile, 153 cases of gastric and cardia cancer who underwent radical surgery were collected as control group.
Data collection
The clinicopathological data including sex, age, surgery properties, tumor region, esophageal involvement, Borrmann type, pathologic type, grading of cancer, T grade, incurable factors, and CA125 value were collected. As some surgeons did not describe the gross specimen in the record, and the grading information was not included in some pathological reports, the Borrmann-type data were complete in 216 cases, and the grading data were complete in 234 cases.
The tumor staging, TNM stage system, and T grade were determined according to the guideline of 2002 American Joint Committee on Cancer (AJCC). Pathological T was used in cases with postoperative histopathologic examination. Surgical staging was used for those cases impossible to acquire pathological T (undergone exploratory or bypass surgery). T status (tumor was unresectable because of its direct infiltration), N status (tumor was unresectable because there were unresectable lymph nodes), peritoneal metastasis (the tumor was unresectable because peritoneal metastasis was found during operation), and distant metastasis (the tumor was unresectable because distant metastasis was found during operation) were categorized as incurable factors.
CA125 measurement
The procedures basically followed our previous study. [11] Blood samples were collected with venipuncture before surgery. Serum was separated by centrifuge and then stored at À20°C until detection. Serum concentration of CA125 was measured by i4000 light-emitting apparatus (Abbott Laboratories Ltd.) with chemiluminescence. Reagent was provided by above company. According to the manufacturer's instructions, the cut-off concentration of CA125 was 35 U/mL.
Statistical analysis
Statistical analyses were performed using SPSS 19.0 (SPSS Inc, Chicago, IL). The analytical procedures basically followed our previous study: [8] 2.4. 
2.4.3.
Step 3. Binary logistic regression with backward: conditional method was performed. Dependent variables were curability, T status, N status, peritoneal metastasis, and distant metastasis. Covariates were the related clinicopathological data from step 1 and the CA125 cut-off points from step 2. Borrmann type and grading were exceptional because some cases had no available Borrmann type or grading data.
2.4.3.1.
Step 4. If Borrmann type or grading factor was one of the related factors, binary logistic regression was then performed again using curability, T status, N status, peritoneal metastasis, or distant metastasis from step 2 as dependent variables and the related clinicopathological data from step 1 and the CA125 Table 1 Associations between curability and clinicopathological data.
Curability
Yes
No P Step 5 If Borrmann type or grading factor was not one of the related factors obtained through binary logistic regression from step 3, the results in step 2 were the final result. However, if Borrmann type or grading factor was the related factor, the results in step 3 were the final result.
Sex
Results
Patient characteristics
Of all the 297 cases, the mean age was 57.93 ± 9.83 years (range 25-81 years) in the radical surgery group and 55.95 ± 10.72 years (range 22-77 years) in the incurable surgery group (P = 0.097). The incurable factors, that is, T status, N status, peritoneal metastasis, and distant metastasis, were categorized in 56, 41, 94, and 11 cases, respectively.
Associations between clinicopathological factors and curability
Of all clinicopathological factors, age, gastric body, gastric antrum, esophageal involvement, T grade, and grading of cancer were associated with curability (Table 1) .
Associations between clinicopathological factors and T status, N status, peritoneal metastasis, or distant metastasis
T status was associated with gastric antrum, esophageal involvement, T grade, Borrmann type, and grading of cancer.
N status was associated with esophageal involvement, T grade, and grading of cancer (Table 2) . Peritoneal metastasis was associated with esophageal involvement, T grade, Borrmann type, and grading of cancer. There were no clinicopathological parameters associated with distant metastasis (Table 3) .
Associations between CA125 value and clinicopathological factors, curability, T status, N status, peritoneal metastasis, or distant metastasis
The CA125 value was significantly higher in incurable, male, T4, and Borrmann type IV gastric and cardia cancer patients (Table 4) . CA125 was also statistically associated with N status, peritoneal metastasis, or distant metastasis (Table 5) .
The ROC curve of CA125 and curability, T status, N status, peritoneal metastasis, distant metastasis
The ROC curves of CA125 and curability (Fig. 1) , T status (Fig. 2) , N status (Fig. 3) , peritoneal metastasis (Fig. 4) , and distant metastasis (Fig. 5) were shown in Figures; 13.95 U/mL, 12.95 U/ mL, 15.75 U/mL, 18.35 U/mL, and 53.55 U/mL were set as cut-off (C), cut-off (T), cut-off (N), cut-off (P), and cut-off (D), respectively.
The cutoff points were then tested by x 2 test (Table 6 ). All the results showed significant differences.
Multivariate analyses for curability, T status, N status, peritoneal metastasis, and distant metastasis
Multivariate analyses of multiple steps (step 4 and step 5 in "statistical analysis" part) were performed. Esophageal involve- ment, T grade, and CA125 (C) were found associated with curability (Table 7) , T grade and Borrmann type were found associated with T status (Table 8) , T grade and CA125 (N) were found associated with T status (Table 9) , age, esophageal involvement, T grade, and CA125 (P) were found associated with T status (Table 10) , and CA125 (D) was found associated with distant metastasis (Table 11 ).
Discussion
Complete surgical resection, with or without adjuvant chemotherapy or radiotherapy, is regarded as the only way to achieve curative treatment for gastric cancer. [12] Current strategies usually define stage 0 to III gastric cancer as curable, which is suitable for radical resection. For patients of stage IV, the curative opportunity may be limited, as it is reported that up to 50% of patients without metastatic disease who undergo "curative" surgical resection present with recurrent disease within 5 years. [13] Surgery for incurable gastric and cardia cancer may also be of importance. Studies have suggested that approximately 20% of patients with stage IV gastric cancer who undergo palliative gastric resection could relieve tumor-related symptoms, avoid tumor-related complications, and improve quality-of-life. [14] Nonresectional procedures are common currently, as it is reported over half of patients with stage IV gastric cancer who receive surgical intervention underwent gastric bypass procedures, gastrostomy, and jejunostomy, etc. [14] However, the risk of surgery for incurable gastric and cardia cancer should not be ignored. A meta-analysis reveals an overall postoperative inhospital mortality of 14% and morbidity of 27% in patients who undergo noncurative gastric surgery for stage IV gastric cancer. [15] So, the decision of surgery should be made cautiously for gastric and cardia cancer patient with unknown curability.
As all the imaging techniques have some limitations in preoperative evaluation of the curability of gastric cancer, [8] looking for some other indicators is necessary. Our previous study [8] reported some clinical parameters associated with the curability of gastric cancer, which, to our knowledge, was the first to evaluate the risk factors for surgery of incurable gastric cancer. Considering the role CA125 plays in the diagnosis, management, and prognosis evaluation of malignant diseases, it is necessary to study the importance of CA125 in the evaluation of curability of gastric and cardia cancer. Nevertheless, no related research about the correlation between CA125 and curability has been reported until now.
Our study found that CA125 was associated with curability and N status, peritoneal metastasis, and distant metastasis. In addition to this, esophageal involvement and T grade were associated with curability. T grade and Borrmann type were associated with T status. T grade was associated with N status. Age, esophageal involvement, T grade, and Borrmann type were associated with peritoneal metastasis.
T grade plays an important role in tumor evaluation. T4 gastric and cardia cancer has involved the serosal surface, even invaded adjacent tissues and organs. Although T4 gastric and cardia cancer patients can benefit from aggressive en bloc surgical resection, [16] some T4 gastric cancer cases are regarded unfit for curative surgery. T4 cases sometimes show marked invasion to adjacent structures, which makes them surgically incurable. [17] Extended curative operation may lead to high incidence of postoperative morbidity and mortality. [16] Serosal surface involvement of T4 gastric cancer means risk for peritoneal dissemination, [18] and peritoneal recurrence is common among patients with T4 primaries who are regarded as curable and undergo resection. [19] T4 gastric cancer is also often combined with metastasis such as lymph node involvement and liver metastasis. [17] Our study revealed that T grade was correlated with, and also a risk factor of, curability, T status, N status, and peritoneal metastasis, which was consistent with previous reports.
The classification of gastric and cardia cancer according to Borrmann criteria is accepted worldwide. Gastric and cardia cancer of different Borrmann type shows different clinical Table 4 Associations between the value of CA125 and clinicopathological data. Table 5 Associations between the value of CA125 and T status, N status, peritoneal metastasis, or distant metastasis. patterns. Type IV gastric cancer is found in 9% of gastric cancer patients, [20] and is associated with advanced tumor progression. Type IV gastric cancer has a poor prognosis, and is even seen as surgically incurable because of the poor outcomes after surgery. [21] Type IV gastric cancer is reported to be correlated with poorly differentiated carcinoma, lymph node metastases, peritoneal metastases, serosal invasion, and lymphatic invasion by a meta-analysis including 15 studies. [22] All these clinical characteristics of type IV gastric and cardia cancer lead to a low curative resection. In our research, Borrmann type IV gastric and cardia cancer was associated with T status, N status, and peritoneal metastasis, which was similar to that observed in other studies. It was a risk factor of T status, too.
CA125 is a repeating peptide epitope of the mucin MUC16. [23] MUC16 can help in the formation of a disadhesive barrier, [24] and in regulating the mucosal defenses of the epithelial cell layer. [25] CA125 is identified as a 5797 -base pair cDNA isolated from the OVCAR-3 cDNA library. [26] It presents at human Figure 1 . The receiver-operating characteristic curve of CA125 and curability. The area below the CA125-curability curve was 0.734 (P = 0.000), the Youden index was maximum when the value was 13.95 U/mL (sensitivity 0.688, specificity 0.673). Figure 2 . The receiver-operating characteristic curve of CA125 and T status. The area below the CA125-T status curve was 0.596 (P = 0.025), the Youden index was maximum when the value was 12.95 U/mL (sensitivity 0.732, specificity 0.498). The area below the CA125-N status curve was 0.670 (P = 0.000), the Youden index was maximum when the value was 15.75 U/mL (sensitivity 0.683, specificity 0.594). Figure 4 . The receiver-operating characteristic curve of CA125 and peritoneal metastasis. The area below the CA125-peritoneal metastasis curve was 0.743 (P = 0.000), the Youden index was maximum when the value was 18.35 U/mL (sensitivity 0.649, specificity 0.768). [27] Predicted glycosylated form of the protein is ∼2 Â 10 7 Da. [28] Its biological function includes promoting cancer cell proliferation and inhibiting anti-cancer immune responses. [29] CA125 is originally found as a specific biological marker for ovarian cancer, and is considered to be a method of diagnosing gastric cancer. [29] It is more frequently positive with peritoneal recurrence, [30] and the importance of CA125 in the evaluation of peritoneal metastasis is suggested. [31] According to Shigenobu et al, [32] Serum CA125 is a clinically useful marker in diagnosis, evaluating the efficacy of chemotherapy, and predicting the prognosis of patients with peritoneal dissemination. The expression of CA125 is found to be an independent predictor of poor outcome not only in gastric adenocarcinomas, but also pancreatic ductal adenocarcinomas and potentially in esophageal adenocarcinomas. [33] Bruce et al [34] find CA125 is predictive for the presence of extrauterine disease in patients with uterine cancer. Another literature reports that the level of CA125 appears to correlate with disease activity, diseasefree and overall survival in patients of non-Hodgkin lymphoma. [35] In our study, CA125 was found to be associated with curability, N status, peritoneal metastasis, and distant metastasis of gastric and cardia cancer. Cutoff points were found, which means CA125 is a biological marker not only for the diagnosis and prognosis, but also potentially for estimating curability. In addition, CA125 was a risk factor of curability, N status, peritoneal metastasis, and distant metastasis. Our results may suggest that CA125 was correlated with tumor metastasis of gastric and cardia cancer.
However, there were still some limitations. As this was a retrospective study, the definition of Borrmann type and grading was not strictly unified, so there may be systematic bias. Besides, the information was incomplete in some patients, which affected the credibility of our study. The number of cases of distant metastasis was limited and relevant results need a larger number of cases to verify.
The result of this study was similar to our previous report. [8] Although both the studies were performed in the same center, the patients enrolled were different. So there were some differences that existed between the results of 2 studies. In short, we found CA125 was statistically associated with the curability and metastasis-related factors (N status, peritoneal metastasis, and Figure 5 . The receiver-operating characteristic curve of CA125 and distant metastasis. The area below the CA125-distant metastasis curve was 0.661 (P = 0.070), the Youden index was maximum when the value was 53.55 U/mL (sensitivity 0.455, specificity 0.878). Table 6 The test of CA125 cutoff points. Table 7 Multivariate analyses for curability. The optimum cut-off point for CA125 (cut-off [C]) was 13.950 U/mL with a sensitivity of 68.8% and a specificity of 67.3%. aOR = adjusted odds ratio. The optimum cutoff point for CA125 (cut-off [N]) was 15.750 U/mL with a sensitivity of 68.3% and a specificity of 59.4%. aOR = adjusted odds ratio. The optimum cut-off point for CA125 (cut-off (P)) was 18.350 U/mL with a sensitivity of 64.9% and a specificity of 76.8%. aOR = adjusted odds ratio. 
Conclusion
Esophageal involvement, T grade, and CA125 were risk factors of curability. T grade and Borrmann type were risk factors of T status. T grade and CA125 were risk factors of N status. Age, esophageal involvement, T grade, and CA125 were risk factors of peritoneal metastasis. CA125 was risk factor of distant metastasis. CA125 was predictive for the evaluation of curability of gastric and cardia cancer. The optimum cut-off point for CA125 (cut-off(D)) was 53.550 U/mL with a sensitivity of 45.5% and a specificity of 87.8%. OR = odds ratio. 
